4 Major Things People Keep Getting Wrong About GLP-1s Despite the increasing prevalence of the drugs, there are a lot of misconceptions swirling about them, During the Flow Space Women's Health Summit this fall, three expert doctors gathered for a panel to fact check these misconceptions and to discuss how midlife women can best use GLP-1s
Piersma et al
Originally developed for the treatment of type 2 diabetes, the medication has shown remarkable efficacy when paired with a healthy diet and regular exercise
Armodafinil for fibromyalgia fatigue
149 Reducing the number of harmful Firmicutes bacteria while increasing the number of Bacteroidetes helps to restore intestinal homeostasis and improve intestinal permeability
Further, whilst real barriers persist, available evidence has indeed corroborated the potential clinical utility of GLP-1 RAs in HF(5), with the most recent GLP-1 RA CVOT (Amplitude-O with once-weekly efpeglenatide) indicating a relative risk reduction for hospitalisation-requiring HF of at least 30% in people with type 2 diabetes (Gerstein et al., 2021)
